Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GP.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.7.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.1.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.2.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.2.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.1.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LB.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDYNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.18.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.4.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KS.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JC.5.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDPNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.2.3.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.2.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LU.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LF.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LB.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
MM.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.7.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.2.3.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LB.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.2.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.1.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LB.1.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LB.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.2.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
MA.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LB.1.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.81NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.20NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBL.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.16.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LW.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LP.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LB.1.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.3.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used